1,046
Views
11
CrossRef citations to date
0
Altmetric
Review

Safety, specificity and immunogenicity of a PrPSc-specific prion vaccine based on the YYR disease specific epitope

, , , , , , , , & show all
Pages 51-59 | Received 29 Nov 2013, Accepted 22 Jan 2014, Published online: 07 Feb 2014

Figures & data

Figure 1. Effects of PrPC immunotherapy on reducing amplification of PrPSc.

Figure 1. Effects of PrPC immunotherapy on reducing amplification of PrPSc.

Figure 2. Effect of conformation-specific immunotherapy on endogenous PrPC and PrPSc.

Figure 2. Effect of conformation-specific immunotherapy on endogenous PrPC and PrPSc.

Figure 3. Mapping of PrPSc DSEs. Location of YML (green), YYR (orange), and RL (red) disease-specific epitopes within tertiary and primary structure of PrP. Adapted from James et al.Citation50

Figure 3. Mapping of PrPSc DSEs. Location of YML (green), YYR (orange), and RL (red) disease-specific epitopes within tertiary and primary structure of PrP. Adapted from James et al.Citation50

Figure 4. Immunogenicity of YYR vaccines in sheep. YYR epitope vaccines were generated as C-terminal fusions to the carrier protein leukotoxin. Epitopes were generated through N and C-terminal expansion of the YYR core, using the PrP protein sequence. In the recombinant protein, epitopes were presented in a repeat motif in either a linear (L) or inverted (I) presentation. Median titers represent serum antibody titers two weeks after a boost immunization.

Figure 4. Immunogenicity of YYR vaccines in sheep. YYR epitope vaccines were generated as C-terminal fusions to the carrier protein leukotoxin. Epitopes were generated through N and C-terminal expansion of the YYR core, using the PrP protein sequence. In the recombinant protein, epitopes were presented in a repeat motif in either a linear (L) or inverted (I) presentation. Median titers represent serum antibody titers two weeks after a boost immunization.

Figure 5. Specificity and safety of conformation-specific immunotherapy. (A) Sheep (n = 7) received the β2(2+YYR+9)I vaccine at 6-wk intervals. Pre-immune and immune serum from high titer animals were evaluated for the ability to bind PrPC via ELISA. (B) Sheep were immunized three times at 6-wk intervals with the either of the various YYR-based vaccines noted. Immune sera conjugated to magnetic beads were used in immunoprecipitation experiments with brain homogenates from uninfected (wt) and scrapie-infected mice (RML). (C) Polyclonal β2(2 + YYR + 9)I coupled to beads was used in immunoprecipitation experiments with lysates from HEK293T cells expressing either wt PrPC or the T194A PrPC mutant. (D) PK digests and western blots of combined brain and spleen homogenates from six β2(2 + YYR + 9)I-vaccinated / aged or infected tga20 mice.

Figure 5. Specificity and safety of conformation-specific immunotherapy. (A) Sheep (n = 7) received the β2(2+YYR+9)I vaccine at 6-wk intervals. Pre-immune and immune serum from high titer animals were evaluated for the ability to bind PrPC via ELISA. (B) Sheep were immunized three times at 6-wk intervals with the either of the various YYR-based vaccines noted. Immune sera conjugated to magnetic beads were used in immunoprecipitation experiments with brain homogenates from uninfected (wt) and scrapie-infected mice (RML). (C) Polyclonal β2(2 + YYR + 9)I coupled to beads was used in immunoprecipitation experiments with lysates from HEK293T cells expressing either wt PrPC or the T194A PrPC mutant. (D) PK digests and western blots of combined brain and spleen homogenates from six β2(2 + YYR + 9)I-vaccinated / aged or infected tga20 mice.

Figure 6. Active immunization and oral challenge of sheep. Pregnant ewes (n = 2/group) received two immunizations of either Lkt or Lkt-β2(2+YYR+9)I vaccine at six and three weeks prior to birthing. Lambs born from Lkt (n = 4) or Lkt-β2(2 + YYR + 9)I (n = 3) vaccinated ewes were challenged with 1 g of scrapie brain homogenate via gastric feeding immediately following birth. Animals were continuously monitored for the onset of scrapie symptoms by 24 h video surveillance.

Figure 6. Active immunization and oral challenge of sheep. Pregnant ewes (n = 2/group) received two immunizations of either Lkt or Lkt-β2(2+YYR+9)I vaccine at six and three weeks prior to birthing. Lambs born from Lkt (n = 4) or Lkt-β2(2 + YYR + 9)I (n = 3) vaccinated ewes were challenged with 1 g of scrapie brain homogenate via gastric feeding immediately following birth. Animals were continuously monitored for the onset of scrapie symptoms by 24 h video surveillance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.